For a lot of pharmacies, spring can feel early to think about flu vaccine. But in practice, this is when flu pre-booking is supposed to happen.
The simplest reason is that the flu vaccine supply chain starts long before flu season does. Each year, vaccine strains are selected months in advance so manufacturers can begin production early enough to have doses ready for the fall. CDC explains that flu vaccine viruses have to be selected many months before flu season so vaccine can be produced and delivered on time.
And the manufacturing process itself is a big part of why that timeline matters. In CDC’s description of the traditional egg-based process, candidate vaccine viruses are sent to manufacturers, injected into fertilized eggs, incubated for several days, harvested, purified, tested, packaged, and then released for shipment. It is a long, staged process, not something that can be turned around quickly once demand starts to build.
That is why pre-book season happens now, and why it benefits pharmacies to act now instead of waiting until flu season feels closer. Pre-booking gives pharmacies an earlier chance to plan around expected need rather than hoping the right product, quantity, and timing are still available later. The American Academy of Pediatrics says pre-booking for the next influenza season begins before the current one is over, and that pre-book periods for manufacturers generally run until the end of March, with additional ordering only if product is available.
In other words, this is not early in the way it may feel. This is the part of the calendar when the vaccine market is already working on the next season. The FDA’s strain composition decision for the 2026–2027 U.S. flu season was published in March, which is a useful reminder of how far upstream the process starts.
That is also why waiting until late summer is not the same thing as pre-booking. Later ordering may still be possible, but it can leave pharmacies working from what remains available instead of planning earlier around expected need. The American Academy of Pediatrics notes that providers who do not pre-book may encounter delays in receipt of influenza vaccine, and CDC says distribution takes place in phases over several months.
There is also a practical planning benefit for pharmacies. Pre-booking gives teams more time to think through expected usage, patient population, storage space, shipment timing, and product selection instead of trying to piece that together later. AAP specifically recommends reviewing doses used, doses left over, likely patient demand for the coming season, and whether storage and staggered shipping plans are in place.
Even in years when demand feels less predictable, that earlier planning still matters. CDC says flu vaccine distribution happens over several months, which is another reminder that later demand and later ordering do not always line up neatly with supply timing.
The bottom line is that pre-book season starts now because flu vaccine production starts now. By the time flu season feels close, strain selection has already happened, manufacturing is underway, and distribution planning is already moving. For pharmacies, that makes spring the right time to plan ahead and reserve supply—not because flu season is already here, but because the work required to support it already is.
That is exactly why we launched the Masters Flu Pre-Book Program now. And because our pre-book program ends April 30, now is the time to act if your pharmacy wants to plan ahead for the coming season.
